3D Tissue Models

This person is not registered. Is this you?


Profile Details
Yuefeng Lu
Affiliations:

Amgen

 
,
Phone:
Fax:
My Blogs:
My Twitter Hashtags:
@OECD
 
Age:
Bio:
 
Specialty:
Cancer Immunotherapy
 
Presented at Events Covering:
, Biotechnology, Chromatography, Hybridoma, Monoclonal, Proteomics
 
Areas of Interest:
 
Hobbies:
 
General Comments:
BSN Rank: 8136 / 3501 (What's this?)
Accomplish Score: 14
Popularity Score: Unavailable
# in My Circle: 0
# in My Org(s): 106
We'll Post Your CV for Free!
 
 
Speaking/Presenting-Abstract/Poster at Mtg: 1 (14 / 0)
 
Honors and Awards: 0 (0 / 0)
 
Clinical Trial Activity: 0 (0 / 0)
 
Grant Support: 0 (0 / 0)
 
Patents Pending: 0 (0 / 0)
 
Journal - Editor/Reviewer: 0 (0 / 0)
 
Peer Reviewed Papers, Books, Chapters: 5 (30 / 0)
  • T lymphoblastic leukemia/lymphoma (T-ALL/LBL) is highly aggressive. ()
  • Epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) has intracranial activity in EGFR-mutant Non-Small Cell Lung Cancer (NSCLC). ()
  • OBJECTIVES: The aim of our study is to evaluate the effect of core needle biopsy (CNB) and subsequent neoadjuvant chemotherapy (NAC) on the expression of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth hormone receptor 2 (HER2) and Ki67 in breast cancer, and the associated influencing factors. ()
 
Pre/Non Reviewed Papers, Proceedings: 0 (0 / 0)
 
Membership in Professional Societies: 0 (0 / 0)
 
White Papers: 0 (0 / 0)
 
Registered on BiotechScienceNews: 0

About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.